Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Rosiglitazone-lipid nanoparticle-CGKRK targeting peptide complex |
| Catalog Number | LNP-049 |
| Size | 10 mg; 25 mg; 50 mg |
| Alias | Rosiglitazone@LNP-CGKRK; Rosiglitazone@LNP-peptide |
| Appearance | Milky white or transparent colloidal solution |
| Solubility | Soluble in organic solvents |
| Description | Rosiglitazone@LNP-CGKRK peptide is an innovative drug delivery complex that combines the research advantages of rosiglitazone with the delivery capabilities of LNP and the targeting properties of CGKRK peptide. Rosiglitazone, a thiazolidinedione drug, can increase insulin sensitivity by activating peroxisome proliferator-activated receptor γ (PPARγ)and effectively assist in controlling blood sugar levels in research models with type 2 diabetes. Lipid nanoparticles (LNP)are composed of ionizable cationic lipids, phospholipids, cholesterol and PEGylated lipids, which can stably encapsulate rosiglitazone, protect it from degradation, prolong the circulation time of the drug in the body, and enhance drug stability. |
| Applications | Targeted antitumor research |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |